The latest trading session saw Teladoc (TDOC) ending at $9.30, denoting a +1.2% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily loss of 0.16%. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq lost 0.06%. For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.05 per share and a revenue of $2.65 billion, signifying shifts of +21.64% and +1.8%, respectively, from the last year. The Zacks Rank system, running from #1 (Str ...

Core Viewpoint - Teladoc Health, Inc. will release its second quarter 2024 results on July 31, 2024, after market close, followed by a conference call to discuss the results [1]. Company Information - Teladoc Health is a leader in whole-person virtual care, aiming to transform the healthcare experience and improve health outcomes through personalized interactions and proprietary health signals [4]. - The company has over two decades of expertise and data-driven insights to address the increasing virtual care needs of consumers and healthcare professionals [4]. Conference Call Details - The conference call will take place at 4:30 p.m. E.T. on July 31, 2024, and will be accessible via a dedicated phone line for U.S. participants and a global dial-in link for international participants [3]. - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [2].

Company Overview - Teladoc Health is a global leader in whole-person virtual care, aiming to empower individuals to live healthier lives by transforming the healthcare experience [3][4] - The company utilizes proprietary health signals and personalized interactions to enhance health outcomes across the entire continuum of care [3] Financial Announcement - Teladoc Health will release its second quarter 2024 results on July 31, 2024, after market close [4] - A conference call to review the results will take place at 4:30 p.m. E.T. on the same day [4] Investor Relations - Investors can access the conference call by dialing 1-833-470-1428 for U.S. participants, with an access code of 453227 [2] - International participants can find global dial-in numbers through a provided link [2] - A live audio webcast will also be available for those who prefer online access [1][5]

Core Insights - Teladoc Health has launched a comprehensive mental healthcare solution for children, adolescents, and their families in partnership with Brightline, aimed at improving access to specialized mental health services [6][11] - The initiative addresses significant gaps in pediatric mental healthcare, particularly the shortage of trained providers and the challenges parents face in seeking help for their children [2][7] Group 1: Company Overview - Teladoc Health is recognized as a global leader in virtual care, utilizing a digital platform to connect members with healthcare providers trained in pediatric and family mental health [6][12] - Brightline is the first virtual behavioral health solution specifically designed for children and families, offering evidence-based treatments and personalized care [4][12] Group 2: Market Challenges - There is a critical shortage of pediatric mental health providers, with only 14 psychiatrists available per 100,000 children, leading to significant barriers in accessing care [7] - A substantial percentage of parents face difficulties in finding appropriate mental health services, with 60% unsure of where to seek help and 50% lacking referrals [7] Group 3: Service Offerings - The new mental health program includes digital support, coaching, therapy, and medication management services tailored to the unique needs of children and families [12] - The partnership aims to facilitate a seamless transition for young clients into the broader Teladoc Health ecosystem once they reach adulthood [2][11]

Core Points - Teladoc Health, Inc. (NYSE: TDOC) is facing a class action lawsuit for misleading statements made during the Class Period from November 2, 2022, to February 20, 2024 [7] - The lawsuit alleges that Teladoc increased its marketing spend despite assurances of a pullback, leading to deteriorating revenue and stagnant membership growth in its BetterHelp division [9] Group 1 - The class action lawsuit claims that Teladoc continued to expand its marketing spend throughout 2023, contrary to public assurances [9] - Increased marketing expenditures on BetterHelp did not yield significant returns, negatively impacting Teladoc's revenue [9] - Despite acknowledging inefficiencies in advertising due to market saturation, Teladoc persisted in increasing its advertising spend [9] Group 2 - The lawsuit indicates that BetterHelp's membership stagnated and then decreased in 2023, attributed to market saturation and ineffective marketing strategies [9] - Investors are reminded of the July 16, 2024, deadline to apply as lead plaintiffs in the class action [7][8] - The Rosen Law Firm, representing investors globally, has a strong track record in securities class actions, having secured significant settlements in the past [2]

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TDOC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 16, 2024. There is no cost or obligation to you to participate in this case. NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Teladoc Health, ...

Analysts and investors alike will be keeping a close eye on the performance of Teladoc in its upcoming earnings disclosure. On that day, Teladoc is projected to report earnings of -$0.35 per share, which would represent yearover-year growth of 12.5%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $649.56 million, down 0.44% from the year-ago period. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. ...

If you suffered substantial losses and wish to serve as lead plaintiff of the Teladoc class action lawsuit, please provide your information here: The Teladoc class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Teladoc continued to expand its marketing spend throughout 2023, despite public assurances that it would pull back its advertising spending; (ii) increased marketing spend on BetterHelp deteriorated Telado ...

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material informat ...

Individuals in Texas who have been displaced or who cannot access medical care as a result of the storm can seek treatment from a licensed health care professional for any non-emergency illness by calling Teladoc Health directly at 855-225-5032. Individuals seeking physician-authorization for prescription refills of non-narcotic drugs can also get assistance. For emergencies, patients should call 911. Teladoc Health deploys resources each year to respond to federally declared natural disasters across the Un ...